Harvard Bioscience Stock Price on September 16, 2024
| HBIO Stock | USD 2.31 0.03 1.28% |
Below is the normalized historical share price chart for Harvard Bioscience extending back to December 07, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Harvard Bioscience stands at 2.31, as last reported on the 11th of December 2024, with the highest price reaching 2.31 and the lowest price hitting 2.31 during the day.
If you're considering investing in Harvard Stock, it is important to understand the factors that can impact its price. Harvard Bioscience holds Efficiency (Sharpe) Ratio of -0.0407, which attests that the entity had a -0.0407% return per unit of risk over the last 3 months. Harvard Bioscience exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Harvard Bioscience's Market Risk Adjusted Performance of (0.03), standard deviation of 4.45, and Risk Adjusted Performance of (0.01) to validate the risk estimate we provide.
At this time, Harvard Bioscience's Total Stockholder Equity is very stable compared to the past year. As of the 11th of December 2024, Capital Stock is likely to grow to about 487.3 K, while Common Stock Shares Outstanding is likely to drop about 33.1 M. . At this time, Harvard Bioscience's Price Book Value Ratio is very stable compared to the past year. As of the 11th of December 2024, Price Earnings To Growth Ratio is likely to grow to 1.07, while Price To Sales Ratio is likely to drop 1.72. Harvard Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of December 2000 | 200 Day MA 3.137 | 50 Day MA 2.3538 | Beta 1.313 |
Harvard |
Sharpe Ratio = -0.0407
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HBIO |
Estimated Market Risk
| 4.46 actual daily | 39 61% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Harvard Bioscience is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Harvard Bioscience by adding Harvard Bioscience to a well-diversified portfolio.
Price Book 1.5558 | Enterprise Value Ebitda 179.2557 | Price Sales 1.0443 | Shares Float 35.5 M | Wall Street Target Price 6.25 |
Related Headline
LeMaitre Vascular Headline on 16th of September 2024
LeMaitre Vascular Surged Due to Robust Global Markets by finance.yahoo.com
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the Carillon Scout Small Cap Fund second quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quarter, the small-cap growth market was down. Higher quality, earners, and larger small caps were among the traits of many of the stocks
Harvard Bioscience Valuation on September 16, 2024
It is possible to determine the worth of Harvard Bioscience on a given historical date. On September 16, 2024 Harvard was worth 2.9 at the beginning of the trading date compared to the closed value of 2.93. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Harvard Bioscience stock. Still, in general, we apply an absolute valuation method to find Harvard Bioscience's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Harvard Bioscience where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Harvard Bioscience's related companies.
| Open | High | Low | Close | Volume | |
| 2.84 | 2.91 | 2.79 | 2.88 | 76,828 | |
09/16/2024 | 2.90 | 2.95 | 2.90 | 2.93 | 62,799 |
| 2.94 | 3.04 | 2.91 | 2.94 | 95,340 |
| Backtest Harvard Bioscience | | | Harvard Bioscience History | | | Harvard Bioscience Valuation | Previous | Next |
Harvard Bioscience Trading Date Momentum on September 16, 2024
| On September 17 2024 Harvard Bioscience was traded for 2.94 at the closing time. The top price for the day was 3.04 and the lowest listed price was 2.91 . The trading volume for the day was 95.3 K. The trading history from September 17, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 0.34% . The trading delta at closing time against the current closing price is 7.85% . |
Harvard Bioscience Fundamentals Correlations and Trends
By evaluating Harvard Bioscience's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Harvard Bioscience's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Harvard financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Harvard Bioscience Stock history
Harvard Bioscience investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Harvard is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Harvard Bioscience will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Harvard Bioscience stock prices may prove useful in developing a viable investing in Harvard Bioscience
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 42.4 M | 33.1 M | |
| Net Loss | -8.6 M | -8.1 M |
Harvard Bioscience Quarterly Net Working Capital |
|
Harvard Bioscience Stock Technical Analysis
Harvard Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Harvard Bioscience Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Harvard Bioscience cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Harvard Bioscience December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Harvard Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Harvard Bioscience shares will generate the highest return on investment. By undertsting and applying Harvard Bioscience stock market strength indicators, traders can identify Harvard Bioscience entry and exit signals to maximize returns
Harvard Bioscience Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Harvard Bioscience's price direction in advance. Along with the technical and fundamental analysis of Harvard Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Harvard to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | (0.04) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harvard Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harvard Bioscience. If investors know Harvard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harvard Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (0.33) | Revenue Per Share 2.258 | Quarterly Revenue Growth (0.13) | Return On Assets (0.02) |
The market value of Harvard Bioscience is measured differently than its book value, which is the value of Harvard that is recorded on the company's balance sheet. Investors also form their own opinion of Harvard Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Harvard Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harvard Bioscience's market value can be influenced by many factors that don't directly affect Harvard Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.